- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02042638
The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism
January 22, 2014 updated by: Aydogan Aydogdu, Gulhane School of Medicine
Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
16
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06018
- Gulhane School of Medicine Dep. of Endocrinology and Metabolism
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 45 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Patients with Idiopathic Hypogonadotropic Hypogonadism
Description
Inclusion Criteria: Serum testosterone concentration < 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -
Exclusion Criteria: Previous androgen treatment, diabetes mellitus, arterial hypertension other hormone deficiencies
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
16 treatment naive Hypogonadotropic hypogonadism patients
Treatment naive 16 patients with idiopathic hypogonadotrophic hypogonadism
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HDL after hCG treatment
Time Frame: 2011-2013
|
2011-2013
|
2011-2013
|
LDL levels after hCG treatment
Time Frame: 2011-2013
|
2011-2013
|
|
total cholesterole levels after hCG treatment
Time Frame: 2011-2013
|
2011-2013
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Body fat ratio after hCG treatment
Time Frame: 2011-2013
|
2011-2013
|
hsCRP levels after hCG treatment
Time Frame: 2011-2013
|
2011-2013
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Fahri Bayram, Proffesor, Erciyes University School of Medicine Depatment of Endocrinology and Metabolism Kayseri TURKEY
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (ACTUAL)
August 1, 2013
Study Completion (ACTUAL)
August 1, 2013
Study Registration Dates
First Submitted
December 28, 2013
First Submitted That Met QC Criteria
January 22, 2014
First Posted (ESTIMATE)
January 23, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
January 23, 2014
Last Update Submitted That Met QC Criteria
January 22, 2014
Last Verified
December 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27122013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Idiopathic Hypogonadotropic Hypogonadism
-
Shanghai Jiao Tong University School of MedicineUnknownIdiopathic Hypogonadotropic Hypogonadism
-
Fudan UniversityRecruitingIdiopathic Hypogonadotropic Hypogonadism | Luteal Phase Support | Luteal Phase DeficiencyChina
-
Massachusetts General HospitalTerminatedHypothalamic Amenorrhea | Idiopathic Hypogonadotropic HypogonadismUnited States
-
Gulhane School of MedicineCompletedIdiopathic Hypogonadotropic Hypogonadism
-
Gulhane School of MedicineCompletedIdiopathic Hypogonadotropic HypogonadismTurkey
-
Gulhane School of MedicineCompletedIdiopathic Hypogonadotropic HypogonadismTurkey
-
Centre Hospitalier Universitaire VaudoisUniversity of LausanneCompletedKallmann Syndrome | Idiopathic Hypogonadotropic Hypogonadism | Congenital Hypogonadotropic HypogonadismSwitzerland
-
Azienda Ospedaliero-Universitaria di ModenaRecruitingAcquired Hypogonadotropic HypogonadismItaly
-
Repros Therapeutics Inc.CompletedObesity | Acquired Hypogonadotropic HypogonadismUnited States
-
Ferring PharmaceuticalsCompletedPrimary Amenorrhea With Hypogonadotropic HypogonadismUnited States, Canada
Clinical Trials on hCG 1500 IU three times a week
-
University of Nove de JulhoRecruitingWrinkle | Facial ExpressionBrazil
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Shahid Beheshti University of Medical SciencesUnknownIntraocular Pressure Changes After Glucosamine Sulfate Consumption.Iran, Islamic Republic of
-
Riyadh Colleges of Dentistry and PharmacyUnknown
-
Universidade Cidade de Sao PauloUnknownOccupational Health | Ergonomics | Manual Material HandlingBrazil
-
Gilead SciencesCompleted
-
Brazilan Center for Studies in DermatologyCompletedTreatment | Striae | Stretch MarksBrazil
-
Gilead SciencesCompletedCystic FibrosisUnited States, Canada, Australia, New Zealand
-
Universidade Federal do Rio de JaneiroCompletedAssessment of Muscle Architecture and Tendon After Chronic Stretching ProgramBrazil